Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease

American Journal of Cardiology

Volumn 88, Issue 1, 2001, Pages 89-92

  Blann, Andrew D ^a   Gurney, David ^a   Hughes, Elizabeth ^b   Buggins, Peter ^b   Silverman, Stanley H ^c   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SANDWELL GENERAL HOSPITAL   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; TURBIDIMETRY;

EID: 0035399663     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01597-1     Document Type: Article

References (18)

1. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
2. The origin of P-selectin as a circulating plasma protein
3. A reliable marker of endothelial function. Does it exist?
4. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
5. Long-term effects of pravastatin on plasma concentration of C-reactive protein
6. Effect of statins on C-reactive protein in patients with coronary artery disease
7. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
8. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: Relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events
9. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolaemia
10. Decrease in P-selectin levels in patients with hypercholesterolaemia and peripheral arterial occlusive disease after lipid-lowering treatment
11. Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients
12. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolaemic patients
13. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
14. The relationship between soluble P-selectin, von Willebrand factor, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
15. Von Willebrand factor and soluble E selectin in hyperlipidaemia: Relationship to lipids and vascular disease
16. Statins do more than just lower cholesterol
17. Lipids and the endothelium